You are here: Home :: Area NEM :: Medical science :: Human medicine :: Internal medicine

Ch. Vetter

Anticoagulation: the present and the future

Because of its central role in the coagulation cascade thrombin is an attractive target for its inhibition. Many limitations of conventional anticoagulants have been eliminated by the development of the direct oral thrombin inhibitor ximelagatran. Thus, this compound may fulfil the criteria of an ideal anticoagulant. The antithrombotic efficacy and safety of this inhibitor is presently studied in a large clinical development program.

Hämostaseologie, Schattauer

Print ISSN: 0720-9355
Volume: 22, 01/2002
Pages: 15 - 20

Show full article (external site)

Show all available items of this journal

 

Area NEM